BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35965274)

  • 1. Vestibular and audiometric results after endolymphatic mastoid shunt surgery in patients with Menière's disease.
    Spiegel JL; Stoycheva I; Weiss BG; Bertlich M; Rader T; Canis M; Ihler F
    Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1131-1145. PubMed ID: 35965274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endolymphatic sac shunt, labyrinthectomy, and vestibular nerve section in Meniere's disease.
    Teufert KB; Doherty J
    Otolaryngol Clin North Am; 2010 Oct; 43(5):1091-111. PubMed ID: 20713247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary role of endolymphatic mastoid shunt surgery in the era of transtympanic perfusion strategies.
    Lee L; Pensak ML
    Ann Otol Rhinol Laryngol; 2008 Dec; 117(12):871-5. PubMed ID: 19140530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of hearing preservation after endolymphatic mastoid sac surgery for Meniere's disease.
    Sun GH; Leung R; Samy RN; McAfee JS; Hearst MJ; Savage CR; Choo DI; Pensak ML
    Laryngoscope; 2010 Mar; 120(3):591-7. PubMed ID: 20131368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratympanic gentamicin therapy for persistent vertigo after endolymphatic sac surgery.
    Marzo SJ; Leonetti JP
    Otolaryngol Head Neck Surg; 2002 Jan; 126(1):31-3. PubMed ID: 11821762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic gentamicin treatment after endolymphatic sac surgery.
    Gouveris H; Lange G; Mann WJ
    Acta Otolaryngol; 2005 Nov; 125(11):1180-3. PubMed ID: 16353396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of vestibular function following endolymphatic sac surgery.
    Gendre A; Bourget-Aguilar K; Calais C; Espitalier F; Bordure P; Michel G
    Eur Arch Otorhinolaryngol; 2022 Mar; 279(3):1193-1201. PubMed ID: 33740085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of endolymphatic sac-mastoid shunt surgery for intractable Meniere's disease].
    Zhang D; Fan Z; Shi H; Han Y; Lyu Y; Li Y; Wang G; Wang H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Sep; 50(9):729-32. PubMed ID: 26696344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Meniere's disease: diagnosis and new treatment perspectives].
    Quaranta A; Piazza F
    Recenti Prog Med; 2000 Jan; 91(1):33-7. PubMed ID: 10705783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meniere's disease: Medical management, rationale for vestibular preservation and suggested protocol in medical failure.
    Christopher LH; Wilkinson EP
    Am J Otolaryngol; 2021; 42(1):102817. PubMed ID: 33202330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of long-term hearing results after vestibular neurectomy, endolymphatic mastoid shunt, and medical therapy.
    Quaranta A; Onofri M; Sallustio V; Iurato S
    Am J Otol; 1997 Jul; 18(4):444-8. PubMed ID: 9233483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A; Aloisi A; De Benedittis G; Scaringi A
    Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent surgical advances and continued controversies in medically refractory Meniere's disease.
    Lucas JC; Hong RS
    Curr Opin Otolaryngol Head Neck Surg; 2023 Oct; 31(5):325-331. PubMed ID: 37266594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of endolymphatic mastoid shunt surgery in the managed care era.
    Pensak ML; Friedman RA
    Am J Otol; 1998 May; 19(3):337-40. PubMed ID: 9596185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endolymphatic sac surgery versus tenotomy of the stapedius and tensor tympani muscles in the management of patients with unilateral definite Meniere's disease.
    Albu S; Babighian G; Amadori M; Trabalzini F
    Eur Arch Otorhinolaryngol; 2015 Dec; 272(12):3645-50. PubMed ID: 25488280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical management of vestibular Meniere's disease with endolymphatic mastoid shunt.
    Miller GW; Welsh RL
    Laryngoscope; 1983 Nov; 93(11 Pt 1):1430-40. PubMed ID: 6633115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
    Rajan GP; Din S; Atlas MD
    J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.